Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease

Citation
B. Vainer et al., Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease, CYTOKINE, 12(10), 2000, pp. 1531-1536
Citations number
31
Categorie Soggetti
Cell & Developmental Biology
Journal title
CYTOKINE
ISSN journal
10434666 → ACNP
Volume
12
Issue
10
Year of publication
2000
Pages
1531 - 1536
Database
ISI
SICI code
1043-4666(200010)12:10<1531:CEASOI>2.0.ZU;2-D
Abstract
A dysregulated local immune reaction with unbalanced cytokine expression se ems essential in inflammatory bowel disease (IBD), i.e. ulcerative colitis (UC) and Crohn's disease (CD), Since the roles of interleukin (IL-)13 and I L-15 remain unclear, this study aimed at studying intestinal expression of IL-13 and IL-15 in IBD, Methods: In colonic biopsies from 24 UC, 18 CD, and 12 controls IL-13 and IL-15 were measured using ELISA, and their gene expr essions were assessed by RT-PCR, Leukocytes were visualised histochemically . Results: Concentrations of IL-13 were decreased in UC (median 56 pg/mg ti ssue; interquartile range 30-99 pg/mg) compared to CD (82 pg/mg tissue; 41- 122; P=0.004) and controls (83 pg/mg tissue; 18-134; P>0.05), and lower in active UC (53 pg/mg tissue; 33-96) than in inactive UC (80 pg/mg tissue; 65 -99; P=0.02). IL-15 concentrations were higher in CD patients (34 pg/mg tis sue; 24-53) as compared to controls (20 pg/mg tissue; 15-21; P=0.001) whils t being 22 pg/mg tissue (15-32) in UC. IL-13 mRNA and IL-15 mRNA were detec ted in 20% and 15%, respectively. Infiltration of leukocytes correlated inv ersely with IL-13 levels (P=0.02), Conclusion: Active UC is associated with decreased colonic IL-13 suggesting that IL-13 levels are diminished as a p art of UC exacerbations, or that exacerbations follow active downregulation of IL-13. (C) 2000 Academic Press.